CZIBERE AKOS (Chief Medical Officer) sold 50K shares of AKTIS ONCOLOGY, INC. on the open market
Open‑market sale worth $1.39M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/10/2026ACC: 0001193125-26-300162
Officer· Chief Medical Officer
Since Jan 2026
-50K
Net shares
Net seller
$1.39M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
50K acquired · 100K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+50K
Price / share
$4.95
Trade value
$247.50K
% of position
New position
7/8/2026
0.00→50K
Common Stock
Direct
Shares
−14.80K
Price / share
$27.13
Trade value
$401.48K
% of position
29.6%
7/8/2026
50K→35.20K
Common Stock
Direct
Shares
−30.83K
Price / share
$27.95
Trade value
$861.74K
% of position
87.6%
7/8/2026
35.20K→4.37K
Common Stock
Direct
Shares
−4.37K
Price / share
$28.71
Trade value
$125.48K
% of position
New position
7/8/2026
4.37K→0.00
Total
Net shares
+0.00
Net value
-$1.14M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | M · Option Exercise | +50K | $4.95 | $247.50K | New position | 0.00 | 50K |
| Common Stock Direct | 7/8/2026 | S · Sale | −14.80K | $27.13 | $401.48K | 29.6% | 50K | 35.20K |
| Common Stock Direct | 7/8/2026 | S · Sale | −30.83K | $27.95 | $861.74K | 87.6% | 35.20K | 4.37K |
| Common Stock Direct | 7/8/2026 | S · Sale | −4.37K | $28.71 | $125.48K | New position | 4.37K | 0.00 |
| Total | +0.00 | -$1.14M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
4.95
Held after
221.22K
Exercisable
—
7/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 7/8/2026 | M · Option Exercise | −50K | 4.95 | — | 221.22K |